Activated T Cells and Soluble Molecules in the Portal Venous Blood of Patients with Cholestatic and Hepatitis C Virus-positive Liver Cirrhosis. Possible Promotion of Fas/FasL-mediated Apoptosis in the Bile-duct Cells and Hepatocyte Injury

By Ariki N   Morimoto Y   Yagi T   Oyama T   Cyouda Y   Sadamori H   Inagaki M   Urushihara N   Iwagaki H   Tanaka N  

The Journal of International Medical Research, Vol. 31, Iss. 3, 2003-05 ,pp. : 170-180

Field House Publishing

Access to resources Recommend Favorite

Invasive and Non-invasive Monitoring of Hepatitis C Virus-Induced Liver Fibrosis: Alternatives or Complements?

By  

Current Pharmaceutical Biotechnology, Vol. 4, Iss. 3, 2003-06 ,pp. : 195-209

Bentham Science Publishers

Access to resources Recommend Favorite

Current and Future Therapy for Chronic Hepatitis C Virus Liver Disease

By  

Current Drug Targets - Infectious Disorders, Vol. 3, Iss. 3, 2003-09 ,pp. : 247-253

Bentham Science Publishers

Access to resources Recommend Favorite

Seroprevalence of Hepatitis C Virus Infection and Evaluation of Serum Aminotransferase Levels among Haemodialysis Patients in Izmir, Turkey

By Olut AI   Ozsakarya F   Dilek M  

The Journal of International Medical Research, Vol. 33, Iss. 6, 2005-11 ,pp. : 641-646

Field House Publishing

Access to resources Recommend Favorite

Infliximab: Hepatitis B virus reactivation and elevated aminotransferase levels: case report

By  

Reactions Weekly, Vol. 1, Iss. 1054, 2005-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite